Cell Therapy And Gene Therapy: A Case Study On Scaling Up For Commercial Manufacturing

There are two new players on the biologics industry block – cell therapy and gene therapy. Join our featured speaker for a discussion of how cell and gene therapies differ from pharmaceuticals and learn about the challenges to achieving commercial manufacturing.

Imagine you are an up-and-coming cell therapy company. You have gone through the exploration phase, with all of its complexities and are in the process of finalizing a breakthrough treatment. At this point, you begin to consider how you can get that cell therapy to a commercial manufacturing setting, with all the tools and systems in place to support the process. The tools and systems that worked well for you in the past may not necessarily work moving forward. There will be a need to consider new tools and new ways of doing things within the company to be successful moving forward.